Annual report pursuant to Section 13 and 15(d)

STOCKHOLDERS??? EQUITY (Details)

v3.22.1
STOCKHOLDERS’ EQUITY (Details)
$ / shares in Units, $ in Thousands
 12 Months Ended
Mar. 30, 2022
shares
May 18, 2021
individual
shares
Dec. 30, 2020
shares
Mar. 31, 2022
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
$ / shares
shares
Mar. 31, 2020
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Aggregate shares purchase (in shares)       60,000 60,000  
Sale of stock (in dollars per share) | $ / shares       $ 1.98 $ 1.98  
Proceeds from warrant exercises | $       $ 119 $ 118  
Restricted stock grants (in shares) 7,500,000 1,031,500,000 15,000      
Share based payment | $       21,600   $ 1,052
Stock-based compensation expense | $       15,745 $ 1,147  
Additional paid in capital            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Share based payment | $       $ 21,600   $ 1,052
Employees and consultants            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of individuals | individual   56        
Executive officers            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Number of individuals | individual   2        
Share-based payment arrangement, tranche one            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Restricted stock grants (in shares) 3,000,000 200,942 4,500      
Vesting period (in years)   1 year 1 year      
Share-based payment arrangement, tranche two            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Restricted stock grants (in shares) 1,500,000 211,658 4,500      
Vesting period (in years)   2 years 2 years      
Share-based payment arrangement, tranche three            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Restricted stock grants (in shares) 1,500,000 206,300 6,000      
Vesting period (in years)   4 years 3 years      
Share-based payment arrangement, tranche three | Minimum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting period (in years)   3 years        
Share-based payment arrangement, tranche three | Maximum            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Vesting period (in years)   5 years        
Share-based payment arrangement, tranche four            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]            
Restricted stock grants (in shares) 1,500,000